I don’t believe the PDD trial in Australia is part of the one in Spain. If it was, it would be a material and would need to be disclosed.
If they were one trial, who would be the one to approve the drug? It doesn’t make sense.
If it were the same trial, Missling would have PRd that info as it would have been some good press. Also, Missling would not have let others break the news on their sites first. Reg FD
It would also cause a delay in finishing the trial which is our closest shot on goal. Why delay a rocket that’s almost ready to launch?
There are many good reasons for the Aussies to run their own PDD. I just don’t know what it is. Missling may be anticipating a request for more info for it to get approved in Australia after Spain approves.
Anyway. I definitely think it’s separate from Spain.
Market Data 
Markets 
AI
